Molecular signature analysis: using the myocardial transcriptome as a biomarker in cardiovascular disease.
about
Gene expression profiling reveals potential prognostic biomarkers associated with the progression of heart failureMicroarray analysis of gene expression: considerations in data mining and statistical treatment.Integrative pathway-centric modeling of ventricular dysfunction after myocardial infarction.Differentially expressed plasma microRNAs and the potential regulatory function of Let-7b in chronic thromboembolic pulmonary hypertension.What are microarrays teaching us about sleep?DNA microarrays in herbal drug researchMethod for generation of in vivo biotinylated recombinant antibodies by yeast mating.Predict, prevent and personalize: Genomic and proteomic approaches to cardiovascular medicineMolecular signatures of obstructive sleep apnea in adults: a review and perspective.Bioinformatic primer for clinical and translational scienceThe antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC-derived cardiomyocytes.The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited.Cardiovascular genetic medicine: genomic assessment of prognosis and diagnosis in patients with cardiomyopathy and heart failureInsights into RNA transcriptome profiling of cardiac tissue in obesity and hypertension conditions.Global gene expression analysis in nonfailing and failing myocardium pre- and postpulsatile and nonpulsatile ventricular assist device support.Gene expression profiling of human hibernating myocardium: increased expression of B-type natriuretic peptide and proenkephalin in hypocontractile vs normally-contracting regions of the heart.
P2860
Q28262080-561C13B2-8985-4CC1-8EEE-FB6B834F67FCQ31034882-B8B27B92-163F-45BA-9FA1-CCA481E0E5BDQ33543006-F410A94A-7F4D-4FD5-B393-31DDFCB33901Q33825547-C96ACB3B-F7B3-4A9C-B5C2-AFC27E4556B6Q34140544-6FF2524F-813A-45B0-865F-59F4070FA018Q35219881-6CB106D5-885F-4C2E-BED4-43EF21131278Q35613964-71B15247-58E2-45B2-AB8D-19573B91DD45Q36898747-AA560F1A-AF2C-4FED-A80D-1D3CA66C93ABQ37146506-1E45ADFC-9499-4F9B-A2D7-DECDE6F8253AQ37307412-6DA56CE1-E840-43A4-A0E9-F0D6C34420F4Q37592520-80B490B6-3886-4CC0-98D3-3BC3E36124D2Q37644606-B658AAA4-A797-4284-95DE-CCF30AB20451Q37766146-1D067C28-45C9-43E2-82EC-37501D8EF50AQ38267844-EE138E40-D807-4509-963F-17014339626BQ45153672-5BA2CAB4-9718-49F9-9691-B217D04B5441Q48856631-D4330D94-55DC-449F-9A8E-D75458FD7D22
P2860
Molecular signature analysis: using the myocardial transcriptome as a biomarker in cardiovascular disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Molecular signature analysis: ...... ker in cardiovascular disease.
@ast
Molecular signature analysis: ...... ker in cardiovascular disease.
@en
type
label
Molecular signature analysis: ...... ker in cardiovascular disease.
@ast
Molecular signature analysis: ...... ker in cardiovascular disease.
@en
prefLabel
Molecular signature analysis: ...... ker in cardiovascular disease.
@ast
Molecular signature analysis: ...... ker in cardiovascular disease.
@en
P1476
Molecular signature analysis: ...... ker in cardiovascular disease.
@en
P2093
Joshua M Hare
Michelle M Kittleson
P304
P356
10.1016/J.TCM.2005.05.007
P577
2005-05-01T00:00:00Z